ORIC Pharmaceuticals, Inc. (ORIC)

NASDAQ: ORIC · Real-Time Price · USD

13.62

+0.12 (0.89%)

At close: Aug 10, 2026, 4:00 PM EDT

13.65

+0.03 (0.22%)

After-hours: Aug 10, 2026, 4:24 PM EDT

ORIC Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	37.48	45.67	59.41	23.38	66.84	226.01
Short-Term Investments	227.28	235.82	196.55	184.8	139.43	10.97
Cash & Short-Term Investments	264.76	281.49	255.96	208.19	206.27	236.98
Cash Growth	-6.28%	9.97%	22.95%	0.93%	-12.96%	-19.29%
Other Current Assets	8.93	6.98	6.29	4.41	4.19	3.54
Total Current Assets	273.7	288.47	262.25	212.6	210.46	240.52
Net Property, Plant & Equipment	2.24	2.42	-	2.86	3.25	2.41
Long-Term Investments	122.8	110.76	2.92	26.85	21.95	43.39
Other Long-Term Assets	5.95	7.25	8.97	9.7	11.52	12.32
Total Assets	404.69	408.89	274.14	252.01	247.18	298.64

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.87	3.82	1.55	0.94	1.32	1.89
Accrued Expenses	16.88	16.59	23.3	19.51	14.07	13.27
Total Current Liabilities	20.76	20.42	24.85	20.46	15.39	15.15
Other Long-Term Liabilities	2.67	4.11	6.17	7.46	9.44	10.52
Total Long-Term Liabilities	2.67	4.11	6.17	7.46	9.44	10.52
Total Liabilities	23.43	24.53	31.02	27.92	24.83	25.67

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	1,152	1,076	805.51	658.75	557.87	518.18
Accumulated Other Comprehensive Income	-1.02	0.79	0.38	0.26	-1.29	-0.1
Retained Earnings	-769.5	-692.24	-562.77	-434.93	-334.23	-245.11
Shareholders' Equity	381.26	384.36	243.12	224.09	222.35	272.98
Total Liabilities & Equity	404.69	408.89	274.14	252.01	247.18	298.64

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	264.76	281.49	255.96	208.19	206.27	236.98
Net Cash Growth	-6.28%	9.97%	22.95%	0.93%	-12.96%	-19.29%
Net Cash Per Share	2.55	3.21	3.67	4.05	5.20	6.24
Book Value	381.26	384.36	243.12	224.09	222.35	272.98
Book Value Per Share	3.67	4.38	3.49	4.36	5.61	7.19
Tangible Book Value	381.26	384.36	243.12	224.09	222.35	272.98
Tangible Book Value Per Share	3.67	4.38	3.49	4.36	5.61	7.19

SEC Filings: 10-K · 10-Q